Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BQ.1.26ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.26ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.26NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
AY.129 (Delta)ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
AY.129 (Delta)ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AY.129 (Delta)ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.129 (Delta)NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
XAY.2.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
XAY.2.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XAY.2.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XAY.2.2NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.3ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.3ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.3ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.3NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.7.10ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.7.10ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.7.10ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.10NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CM.8.1.4ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CM.8.1.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CM.8.1.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CM.8.1.4NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.7.5.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.7.5.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.7.5.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.5.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BE.1.2.1ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BE.1.2.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BE.1.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BE.1.2.1NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.7.7ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.7.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.7.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BF.7.7NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BQ.1.1.34ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BQ.1.1.34ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BQ.1.1.34ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BQ.1.1.34NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BA.4.7ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BA.4.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.4.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.4.7NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
CH.1.1.5ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
CH.1.1.5ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CH.1.1.5ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CH.1.1.5NUS-CDC-N-2TTACAAACATTGGCCGCAAA20402916429183F-21115.5US
BF.7.2ORF1abPasteur-ORF1ab-2CTGGTCAAGGTTAATATAGG20401418614167R-18348.8France
BF.7.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BF.7.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used